Table 2.
Country/Group | Treatment |
---|---|
Belgium/EORTC | Bevacizumab + radiochemotherapy (capecitabine + oxaliplatin) |
Italy | Bevacizumab + radiochemotherapy (capecitabine) |
The Netherlands | Bevacizumab + radiochemotherapy (capecitabine) |
NCI/ECOG | Bevacizumab + radiochemotherapy (capecitabine + oxaliplatin) |
ECOG = Eastern Cooperative Oncology Group; EORTC = European Organisation for Research and Treatment of Cancer; NCI = National Cancer Institute.